Unknown

Dataset Information

0

Risk indicators associated with in-hospital mortality and severity in patients with diabetes mellitus and confirmed or clinically suspected COVID-19.


ABSTRACT:

Purpose

This study aims to investigate risk indicators of in-hospital mortality and severity of coronavirus disease-2019 (COVID-19) in patients with diabetes mellitus (DM).

Methods

In this retrospective study, we studied patients with COVID-19 referred to Sina Hospital, Tehran, Iran, from February 20 to May 14, 2020. Patients with either a positive real-time reverse-transcriptase polymerase-chain-reaction test of swab specimens or high clinical suspicion according to the World Health Organization interim guidance were included. We accurately divided all patients into two groups based on diabetes affection and followed-up patients with DM based on incurring death, severe COVID-19, and in-hospital complications.

Results

We enrolled 574 patients with COVID-19 in the final analysis, of whom 176 (30.7%) patients had DM. In this study, 104 (18.1%) patients deceased, and 380 (66.2%) patients incurred severe COVID-19. We found that COVID-19 patients with DM had a significantly higher mortality rate (P value<0.001), severe disease (P value<0.001), and in-hospital complications (all P values<0.05). Besides that, in patients with DM, admission temperature (odds ratio (OR): 1.69, P value: 0.024), oxygen saturation (OR: 0.92, P value: 0.004), and urea (OR: 1.01, P value: 0.048) were independent risk indicators of in-hospital mortality. In addition, subgroup analysis of diabetic patients based on admission glucose level showed significant differences between these groups regarding acute cardiac injury (P value: 0.044) and acute liver injury (P value: 0.002).

Conclusions

Patients with DM admitted with lower oxygen saturation, elevated temperature, and higher urea are more susceptible to progress to more severe COVID-19 and poor prognosis. This indicates a necessity for more precise care during hospitalization for these patients.

Supplementary information

The online version contains supplementary material available at 10.1007/s40200-020-00701-2.

SUBMITTER: Pazoki M 

PROVIDER: S-EPMC7788281 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7200339 | biostudies-literature
| S-EPMC7404893 | biostudies-literature
| S-EPMC9000124 | biostudies-literature
| S-EPMC8989748 | biostudies-literature
| S-EPMC8231697 | biostudies-literature
| S-EPMC8005367 | biostudies-literature
| S-EPMC9229324 | biostudies-literature
| S-EPMC7997306 | biostudies-literature
| S-EPMC7340186 | biostudies-literature
| S-EPMC7456278 | biostudies-literature